Login
CareDx Inc logo

CareDx Inc

caredx.com

CareDx Inc (NASDAQ: CDNA) is a transplant medicine company that provides surveillance and diagnostic solutions for organ transplant recipients and transplant centers. The provided filing excerpts do not contain sufficient detail to describe CareDx's revenue model, segment breakdown, product portfolio, competitive position, geographic footprint, leadership, or founding history with the specificity required by these writing rules. All fields below reflect only what the 10-K filing excerpt (accession 000121723426000018, filed 2026-02-25) directly supports. The excerpt provided is limited to the SEC cover page boilerplate and does not include the business description, financial statements, or management discussion sections needed to produce a grounded company summary.

Financial Snapshot

Revenue
TTM
$458.1M
Gross Margin
TTM
69.34%
Net Income
TTM
$111.0M
Current Assets
2026 Q2
Current Liabilities
2026 Q2
Current Ratio
2026 Q2
458.09%
Total Assets
2026 Q2
Total Liabilities
2026 Q2
Book Value
2026 Q2
$425.6M
Cash
2026 Q2
P/E
TTM
20.34
Free Cash Flow
TTM
$55.28M

Stock Price

Loading...
Market Cap: $2.258 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support